CRMT Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares ASRV Q1 2026 Earnings Stable EPS at 011 Amidst Flat Market Response LWLG Q3 2024 Earnings Continued RD Investment as Revenue Yet to Materialize Halozyme Therapeutics Inc HALO Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Disclosure BGSI Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Edges Lower Satellos Bioscience Q1 2026 Earnings Narrower Loss Reported Stock Slips on Lack of Revenue Progress